Itsuki Anzai
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
iEvac-Z, an Inactivated Ebola Vaccine - Phase 1 Study in Japan.
Journal: The New England journal of medicine
Published: July 29, 2026
Synthesis of Low-Molecular-Weight Fucoidan Analogue and Its Inhibitory Activities against Heparanase and SARS-CoV-2 Infection.
Journal: Angewandte Chemie (International ed. in English)
Published: June 23, 2024
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain.
Journal: Microbiology spectrum
Published: February 28, 2024
Electrolyzed hypochlorous acid water exhibits potent disinfectant activity against various viruses through irreversible protein aggregation.
Journal: Frontiers in microbiology
Published: August 28, 2023
Epoxidized graphene grid for highly efficient high-resolution cryoEM structural analysis.
Journal: Scientific reports
Published: November 18, 2022
Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant.
Journal: Journal of biochemistry
Published: September 25, 2022
Establishment and clinical application of SARS-CoV-2 catch column.
Journal: Clinical and experimental nephrology
Published: September 06, 2022
Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein.
Journal: Scientific reports
Published: August 08, 2022
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.
Journal: Communications biology
Published: November 10, 2021
Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses.
Journal: PLoS pathogens
Published: November 05, 2021
Last Updated: 09/26/2026